Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Interleukin-17 in rheumatoid arthritis: Trials and tribulations.

Taams LS.

J Exp Med. 2020 Mar 2;217(3). pii: e20192048. doi: 10.1084/jem.20192048.

PMID:
32023342
2.

Mechanisms of checkpoint inhibition-induced adverse events.

Urwyler P, Earnshaw I, Bermudez M, Perucha E, Wu W, Ryan S, Mcdonald L, Karagiannis SN, Taams LS, Powell N, Cope A, Papa S.

Clin Exp Immunol. 2020 Jan 28. doi: 10.1111/cei.13421. [Epub ahead of print] Review.

PMID:
31989585
3.

Presence, function, and regulation of IL-17F-expressing human CD4+ T cells.

Burns LA, Maroof A, Marshall D, Steel KJA, Lalnunhlimi S, Cole S, Catrina A, Kirkham B, Taams LS.

Eur J Immunol. 2019 Dec 18. doi: 10.1002/eji.201948138. [Epub ahead of print]

PMID:
31850514
4.

Anti-TNF treatment negatively regulates human CD4+ T-cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype.

Povoleri GAM, Lalnunhlimi S, Steel KJA, Agrawal S, O'Byrne AM, Ridley M, Kordasti S, Frederiksen KS, Roberts CA, Taams LS.

Eur J Immunol. 2019 Nov 13. doi: 10.1002/eji.201948190. [Epub ahead of print]

PMID:
31722123
5.

Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+ T Cells in Psoriatic Arthritis.

Steel KJA, Srenathan U, Ridley M, Durham LE, Wu SY, Ryan SE, Hughes CD, Chan E, Kirkham BW, Taams LS.

Arthritis Rheumatol. 2019 Nov 2. doi: 10.1002/art.41156. [Epub ahead of print]

PMID:
31677365
6.

Neuroimmune interactions: how the nervous and immune systems influence each other.

Taams LS.

Clin Exp Immunol. 2019 Sep;197(3):276-277. doi: 10.1111/cei.13355.

PMID:
31412421
7.

The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells.

Perucha E, Melchiotti R, Bibby JA, Wu W, Frederiksen KS, Roberts CA, Hall Z, LeFriec G, Robertson KA, Lavender P, Gerwien JG, Taams LS, Griffin JL, de Rinaldis E, van Baarsen LGM, Kemper C, Ghazal P, Cope AP.

Nat Commun. 2019 Jan 30;10(1):498. doi: 10.1038/s41467-019-08332-9.

8.

Delivery of miR-146a to Ly6Chigh Monocytes Inhibits Pathogenic Bone Erosion in Inflammatory Arthritis.

Ammari M, Presumey J, Ponsolles C, Roussignol G, Roubert C, Escriou V, Toupet K, Mausset-Bonnefont AL, Cren M, Robin M, Georgel P, Nehmar R, Taams L, Grün J, Grützkau A, Häupl T, Pers YM, Jorgensen C, Duroux-Richard I, Courties G, Apparailly F.

Theranostics. 2018 Nov 13;8(21):5972-5985. doi: 10.7150/thno.29313. eCollection 2018.

9.

Comparative analysis of immune cell subsets in peripheral blood from patients with periodontal disease and healthy controls.

Cheng WC, Saleh F, Abuaisha Karim B, Hughes FJ, Taams LS.

Clin Exp Immunol. 2018 Dec;194(3):380-390. doi: 10.1111/cei.13205. Epub 2018 Oct 21.

10.

IL-17 in the immunopathogenesis of spondyloarthritis.

Taams LS, Steel KJA, Srenathan U, Burns LA, Kirkham BW.

Nat Rev Rheumatol. 2018 Aug;14(8):453-466. doi: 10.1038/s41584-018-0044-2. Review.

PMID:
30006601
11.

Inflammation and immune resolution.

Taams LS.

Clin Exp Immunol. 2018 Jul;193(1):1-2. doi: 10.1111/cei.13155.

12.

A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT).

Irvine AD, Jones AP, Beattie P, Baron S, Browne F, Ashoor F, O'Neill L, Rosala-Hallas A, Sach T, Spowart C, Taams L, Walker C, Wan M, Webb N, Williamson P, Flohr C; TREAT Trial Investigators.

Br J Dermatol. 2018 Dec;179(6):1297-1306. doi: 10.1111/bjd.16717. Epub 2018 Oct 28.

PMID:
29727479
13.

Anniversary perspective from the Editor-in-Chief.

Taams L.

Clin Exp Immunol. 2018 May;192(2):139-141. doi: 10.1111/cei.13129. No abstract available.

14.

Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1.

Kavanagh Williamson M, Coombes N, Juszczak F, Athanasopoulos M, Khan MB, Eykyn TR, Srenathan U, Taams LS, Dias Zeidler J, Da Poian AT, Huthoff H.

Viruses. 2018 Mar 7;10(3). pii: E114. doi: 10.3390/v10030114.

15.

Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma.

Brencicova E, Jagger AL, Evans HG, Georgouli M, Laios A, Attard Montalto S, Mehra G, Spencer J, Ahmed AA, Raju-Kankipati S, Taams LS, Diebold SS.

PLoS One. 2017 Apr 14;12(4):e0175712. doi: 10.1371/journal.pone.0175712. eCollection 2017.

16.

TNF Blockade Maintains an IL-10+ Phenotype in Human Effector CD4+ and CD8+ T Cells.

Roberts CA, Durham LE, Fleskens V, Evans HG, Taams LS.

Front Immunol. 2017 Feb 15;8:157. doi: 10.3389/fimmu.2017.00157. eCollection 2017.

17.

Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.

Bommarito D, Hall C, Taams LS, Corrigall VM.

Clin Exp Immunol. 2017 Jun;188(3):455-466. doi: 10.1111/cei.12949. Epub 2017 Apr 3.

18.

MicroRNA-155 contributes to enhanced resistance to apoptosis in monocytes from patients with rheumatoid arthritis.

Rajasekhar M, Olsson AM, Steel KJ, Georgouli M, Ranasinghe U, Brender Read C, Frederiksen KS, Taams LS.

J Autoimmun. 2017 May;79:53-62. doi: 10.1016/j.jaut.2017.01.002. Epub 2017 Jan 22.

19.

Psoriatic arthritis.

Durham LE, Taams LS, Kirkham BW.

Br J Hosp Med (Lond). 2016 Jul;77(7):C102-8. doi: 10.12968/hmed.2016.77.7.C102. Review. No abstract available.

PMID:
27388392
20.

Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses.

Cheng WC, van Asten SD, Burns LA, Evans HG, Walter GJ, Hashim A, Hughes FJ, Taams LS.

Eur J Immunol. 2016 Sep;46(9):2211-21. doi: 10.1002/eji.201545871. Epub 2016 Aug 1.

Supplemental Content

Loading ...
Support Center